{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T14:57:22Z","timestamp":1757775442166},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2019,6,27]],"date-time":"2019-06-27T00:00:00Z","timestamp":1561593600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,6,27]],"date-time":"2019-06-27T00:00:00Z","timestamp":1561593600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1007\/s00210-019-01676-5","type":"journal-article","created":{"date-parts":[[2019,6,27]],"date-time":"2019-06-27T14:02:57Z","timestamp":1561644177000},"page":"1393-1400","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Antinociceptive and antidepressive efficacies of the combined ineffective doses of S-ketamine and URB597"],"prefix":"10.1007","volume":"392","author":[{"given":"Mohaddeseh","family":"Ebrahimi-Ghiri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faezeh","family":"Shahini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatemeh","family":"Khakpai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad-Reza","family":"Zarrindast","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,6,27]]},"reference":[{"key":"1676_CR1","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.biopha.2018.10.033","volume":"109","author":"S Alijanpour","year":"2019","unstructured":"Alijanpour S, Khakpai F, Ebrahimi-Ghiri M, Zarrindast MR (2019) Co-administration of the low dose of orexin and nitrergic antagonists induces an antidepressant-like effect in mice. Biomed Pharmacother 109:589\u2013594. \n                    https:\/\/doi.org\/10.1016\/j.biopha.2018.10.033","journal-title":"Biomed Pharmacother"},{"key":"1676_CR2","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1124\/pr.112.006387","volume":"65","author":"JL Blankman","year":"2013","unstructured":"Blankman JL, Cravatt BF (2013) Chemical probes of endocannabinoid metabolism. Pharmacol Rev 65:849\u2013871. \n                    https:\/\/doi.org\/10.1124\/pr.112.006387","journal-title":"Pharmacol Rev"},{"key":"1676_CR3","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/j.biopsych.2006.12.001","volume":"62","author":"M Bortolato","year":"2007","unstructured":"Bortolato M, Mangieri RA, Fu J, Kim JH, Arguello O, Duranti A, Tontini A, Mor M, Tarzia G, Piomelli D (2007) Antidepressant-like activity of the fatty acid amide hydrolase inhibitor URB597 in a rat model of chronic mild stress. Biol Psychiatry 62:1103\u20131110. \n                    https:\/\/doi.org\/10.1016\/j.biopsych.2006.12.001","journal-title":"Biol Psychiatry"},{"key":"1676_CR4","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.neuropharm.2006.02.007","volume":"51","author":"T Christoph","year":"2006","unstructured":"Christoph T, Schiene K, Englberger W, Parsons CG, Chizh BA (2006) The antiallodynic effect of NMDA antagonists in neuropathic pain outlasts the duration of the in vivo NMDA antagonism. Neuropharmacology 51:12\u201317. \n                    https:\/\/doi.org\/10.1016\/j.neuropharm.2006.02.007","journal-title":"Neuropharmacology"},{"key":"1676_CR5","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1097\/00000542-197310000-00003","volume":"39","author":"ML Cohen","year":"1973","unstructured":"Cohen ML, Chan SL, Way WL, Trevor AJ (1973) Distribution in the brain and metabolism of ketamine in the rat after intravenous administration. Anesthesiology 39:370\u2013376","journal-title":"Anesthesiology"},{"key":"1676_CR6","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1177\/1073858408322675","volume":"14","author":"R Corlew","year":"2008","unstructured":"Corlew R, Brasier DJ, Feldman DE, Philpot BD (2008) Presynaptic NMDA receptors: newly appreciated roles in cortical synaptic function and plasticity. Neuroscientist 14:609\u2013625. \n                    https:\/\/doi.org\/10.1177\/1073858408322675","journal-title":"Neuroscientist"},{"key":"1676_CR7","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1111\/j.1526-4637.2004.04043.x","volume":"5","author":"GE Correll","year":"2004","unstructured":"Correll GE, Maleki J, Gracely EJ, Muir JJ, Harbut RE (2004) Subanesthetic ketamine infusion therapy: a retrospective analysis of a novel therapeutic approach to complex regional pain syndrome. Pain Med 5:263\u2013275. \n                    https:\/\/doi.org\/10.1111\/j.1526-4637.2004.04043.x","journal-title":"Pain Med"},{"key":"1676_CR8","first-page":"74","volume":"72","author":"FE D\u2019Amour","year":"1941","unstructured":"D\u2019Amour FE, Smith DL (1941) A method for determining loss of pain sensation. J Pharmacol Exp Ther 72:74\u201379","journal-title":"J Pharmacol Exp Ther"},{"issue":"Suppl 6","key":"1676_CR9","first-page":"7","volume":"61","author":"PL Delgado","year":"2000","unstructured":"Delgado PL (2000) Depression: the case for a monoamine deficiency. J Clin Psychiatry 61(Suppl 6):7\u201311","journal-title":"J Clin Psychiatry"},{"key":"1676_CR10","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.jpain.2017.12.002","volume":"19","author":"RCM Ferreira","year":"2018","unstructured":"Ferreira RCM, Castor MGM, Piscitelli F, di Marzo V, Duarte IDG, Romero TRL (2018) The involvement of the endocannabinoid system in the peripheral antinociceptive action of ketamine. J Pain 19:487\u2013495. \n                    https:\/\/doi.org\/10.1016\/j.jpain.2017.12.002","journal-title":"J Pain"},{"key":"1676_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ijnp\/pyv095","volume":"19","author":"M Fitzgibbon","year":"2015","unstructured":"Fitzgibbon M, Finn DP, Roche M (2015) High times for painful blues: the endocannabinoid system in pain-depression comorbidity. Int J Neuropsychopharmacol 19:1\u201320. \n                    https:\/\/doi.org\/10.1093\/ijnp\/pyv095","journal-title":"Int J Neuropsychopharmacol"},{"key":"1676_CR12","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.pnpbp.2007.07.027","volume":"32","author":"LSB Garcia","year":"2008","unstructured":"Garcia LSB, Comim CM, Valvassori SS, R\u00e9us GZ, Barbosa LM, Andreazza AC, Stertz L, Fries GR, Gavioli EC, Kapczinski F, Quevedo J (2008) Acute administration of ketamine induces antidepressant-like effects in the forced swimming test and increases BDNF levels in the rat hippocampus. Prog Neuro-Psychopharmacol Biol Psychiatry 32:140\u2013144. \n                    https:\/\/doi.org\/10.1016\/j.pnpbp.2007.07.027","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"1676_CR13","doi-asserted-by":"publisher","first-page":"18620","DOI":"10.1073\/pnas.0509591102","volume":"102","author":"G Gobbi","year":"2005","unstructured":"Gobbi G, Bambico FR, Mangieri R, Bortolato M, Campolongo P, Solinas M, Cassano T, Morgese MG, Debonnel G, Duranti A, Tontini A, Tarzia G, Mor M, Trezza V, Goldberg SR, Cuomo V, Piomelli D (2005) Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis. Proc Natl Acad Sci U S A 102:18620\u201318625. \n                    https:\/\/doi.org\/10.1073\/pnas.0509591102","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1676_CR14","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1046\/j.1471-4159.1998.70020671.x","volume":"70","author":"AJ Hampson","year":"2002","unstructured":"Hampson AJ, Bornheim LM, Scanziani M, Yost CS, Gray AT, Hansen BM, Leonoudakis DJ, Bickler PE (2002) Dual effects of anandamide on NMDA receptor-mediated responses and neurotransmission. J Neurochem 70:671\u2013676. \n                    https:\/\/doi.org\/10.1046\/j.1471-4159.1998.70020671.x","journal-title":"J Neurochem"},{"issue":"4","key":"1676_CR15","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.3892\/mmr.2016.5585","volume":"14","author":"Wen-Juan Huang","year":"2016","unstructured":"Huang WENJ, Chen WEIWEI, Zhang XIA (2016) Endocannabinoid system: role in depression , reward and pain control (Review):2899\u20132903. \n                    https:\/\/doi.org\/10.3892\/mmr.2016.5585","journal-title":"Molecular Medicine Reports"},{"key":"1676_CR16","first-page":"97","volume":"47","author":"A Jagtap","year":"2013","unstructured":"Jagtap A, Bhaskar M (2013) Evaluation of antidepressant and antinociceptive activity of escitalopram. Indian J Pharm Educ Res 47:97\u2013102","journal-title":"Indian J Pharm Educ Res"},{"key":"1676_CR17","doi-asserted-by":"publisher","unstructured":"Jiang H, Gong D, Zhou C (2018) Inhibition of fatty acid amide hydrolase improves depressive-like behaviors independent of its peripheral antinociceptive effects in a rat model of neuropathic pain. XXX:1\u201311. \n                    https:\/\/doi.org\/10.1213\/ANE.0000000000003563","DOI":"10.1213\/ANE.0000000000003563"},{"key":"1676_CR18","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.12688\/f1000research.11372.1","volume":"6","author":"K Jonkman","year":"2017","unstructured":"Jonkman K, Dahan A, van de Donk T, Aarts L, Niesters M, van Velzen M (2017) Ketamine for pain. F1000Research 6:1711. \n                    https:\/\/doi.org\/10.12688\/f1000research.11372.1","journal-title":"F1000Research"},{"key":"1676_CR19","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/S0304-3959(02)00122-7","volume":"101","author":"E Jorum","year":"2003","unstructured":"Jorum E, Warncke T, Stubhaug A (2003) Cold allodynia and hyperalgesia in neuropathic pain: the effect of N-methyl-D-aspartate (NMDA) receptor antagonist ketamine--a double-blind, cross-over comparison with alfentanil and placebo. Pain 101:229\u2013235","journal-title":"Pain"},{"key":"1676_CR20","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1124\/jpet.109.155465","volume":"330","author":"SG Kinsey","year":"2009","unstructured":"Kinsey SG, Long JZ, O\u2019Neal ST et al (2009) Blockade of endocannabinoid-degrading enzymes attenuates neuropathic pain. J Pharmacol Exp Ther 330:902\u2013910. \n                    https:\/\/doi.org\/10.1124\/jpet.109.155465","journal-title":"J Pharmacol Exp Ther"},{"key":"1676_CR21","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1007\/BF03016530","volume":"52","author":"S Koizuka","year":"2005","unstructured":"Koizuka S, Obata H, Sasaki M, Saito S, Goto F (2005) Systemic ketamine inhibits hypersensitivity after surgery via descending inhibitory pathways in rats. Can J Anaesth 52:498\u2013505. \n                    https:\/\/doi.org\/10.1007\/BF03016530","journal-title":"Can J Anaesth"},{"key":"1676_CR22","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1126\/science.1190287","volume":"329","author":"N Li","year":"2010","unstructured":"Li N, Lee B, Liu R-J, Banasr M, Dwyer JM, Iwata M, Li XY, Aghajanian G, Duman RS (2010) mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science 329:959\u2013964. \n                    https:\/\/doi.org\/10.1126\/science.1190287","journal-title":"Science"},{"key":"1676_CR23","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1111\/j.1460-9568.2010.07351.x","volume":"32","author":"XJ Liu","year":"2010","unstructured":"Liu XJ, Salter MW (2010) Glutamate receptor phosphorylation and trafficking in pain plasticity in spinal cord dorsal horn. Eur J Neurosci 32:278\u2013289. \n                    https:\/\/doi.org\/10.1111\/j.1460-9568.2010.07351.x","journal-title":"Eur J Neurosci"},{"key":"1676_CR24","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1124\/jpet.109.156216.Cannabinoid","volume":"331","author":"Q Liu","year":"2009","unstructured":"Liu Q, Bhat M, Bowen WD, Cheng J (2009) Signaling pathways from cannabinoid receptor-1 activation to inhibition of n-methyl- d -aspartic acid mediated calcium influx and neurotoxicity in dorsal root ganglion. Neurons 331:1062\u20131070. \n                    https:\/\/doi.org\/10.1124\/jpet.109.156216.Cannabinoid","journal-title":"Neurons"},{"key":"1676_CR25","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1097\/00002826-199508000-00008","volume":"18","author":"MB Max","year":"1995","unstructured":"Max MB, Byas-Smith MG, Gracely RH, Bennett GJ (1995) Intravenous infusion of the NMDA antagonist, ketamine, in chronic posttraumatic pain with allodynia: a double-blind comparison to alfentanil and placebo. Clin Neuropharmacol 18:360\u2013368","journal-title":"Clin Neuropharmacol"},{"key":"1676_CR26","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1523\/JNEUROSCI.17-08-02921.1997","volume":"17","author":"B Moghaddam","year":"1997","unstructured":"Moghaddam B, Adams B, Verma A, Daly D (1997) Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. J Neurosci 17:2921\u20132927","journal-title":"J Neurosci"},{"key":"1676_CR27","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0006-3223(99)00173-0","volume":"46","author":"JC Nelson","year":"1999","unstructured":"Nelson JC (1999) A review of the efficacy of serotonergic and noradrenergic reuptake inhibitors for treatment of major depression. Biol Psychiatry 46:1301\u20131308","journal-title":"Biol Psychiatry"},{"key":"1676_CR28","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1213\/01.ANE.0000067406.52093.BF","volume":"97","author":"M Oatway","year":"2003","unstructured":"Oatway M, Reid A, Sawynok J (2003) Peripheral antihyperalgesic and analgesic actions of ketamine and amitriptyline in a model of mild thermal injury in the rat. Anesth Analg 97:168\u2013173 table of contents","journal-title":"Anesth Analg"},{"key":"1676_CR29","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.neulet.2019.01.059","volume":"699","author":"D d F Pacheco","year":"2019","unstructured":"Pacheco D d F, Romero TRL, Duarte IDG (2019) Ketamine induces central antinociception mediated by endogenous cannabinoids and activation of CB1 receptors. Neurosci Lett 699:140\u2013144. \n                    https:\/\/doi.org\/10.1016\/j.neulet.2019.01.059","journal-title":"Neurosci Lett"},{"key":"1676_CR30","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.neulet.2016.03.051","volume":"620","author":"TL Petryshen","year":"2016","unstructured":"Petryshen TL, Lewis MC, Dennehy KA, Garza JC, Fava M (2016) Antidepressant-like effect of low dose ketamine and scopolamine co-treatment in mice. Neurosci Lett 620:70\u201373. \n                    https:\/\/doi.org\/10.1016\/j.neulet.2016.03.051","journal-title":"Neurosci Lett"},{"key":"1676_CR31","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/j.1527-3458.2006.00021.x","volume":"12","author":"D Piomelli","year":"2006","unstructured":"Piomelli D, Tarzia G, Duranti A, Tontini A, Mor M, Compton TR, Dasse O, Monaghan EP, Parrott JA, Putman D (2006) Pharmacological profile of the selective FAAH inhibitor KDS-4103 (URB597). CNS Drug Rev 12:21\u201338. \n                    https:\/\/doi.org\/10.1111\/j.1527-3458.2006.00021.x","journal-title":"CNS Drug Rev"},{"key":"1676_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphar.2017.00200","volume":"8","author":"P Ratano","year":"2017","unstructured":"Ratano P, Palmery M, Trezza V, Campolongo P (2017) Cannabinoid modulation of memory consolidation in rats: beyond the role of cannabinoid receptor subtype 1. Front Pharmacol 8:1\u201313. \n                    https:\/\/doi.org\/10.3389\/fphar.2017.00200","journal-title":"Front Pharmacol"},{"key":"1676_CR33","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s00213-010-2121-3","volume":"215","author":"V Ricci","year":"2011","unstructured":"Ricci V, Martinotti G, Gelfo F, Tonioni F, Caltagirone C, Bria P, Angelucci F (2011) Chronic ketamine use increases serum levels of brain-derived neurotrophic factor. Psychopharmacology 215:143\u2013148. \n                    https:\/\/doi.org\/10.1007\/s00213-010-2121-3","journal-title":"Psychopharmacology"},{"key":"1676_CR34","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1124\/jpet.107.119941","volume":"322","author":"R Russo","year":"2007","unstructured":"Russo R, Loverme J, La Rana G et al (2007) The fatty acid amide hydrolase inhibitor URB597 (cyclohexylcarbamic acid 3\u2032-carbamoylbiphenyl-3-yl ester) reduces neuropathic pain after oral administration in mice. J Pharmacol Exp Ther 322:236\u2013242. \n                    https:\/\/doi.org\/10.1124\/jpet.107.119941","journal-title":"J Pharmacol Exp Ther"},{"key":"1676_CR35","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1089\/ars.2012.5100","volume":"19","author":"P Sanchez-Blazquez","year":"2013","unstructured":"Sanchez-Blazquez P, Rodriguez-Munoz M, Vicente-Sanchez A, Garzon J (2013) Cannabinoid receptors couple to NMDA receptors to reduce the production of NO and the mobilization of zinc induced by glutamate. Antioxid Redox Signal 19:1766\u20131782. \n                    https:\/\/doi.org\/10.1089\/ars.2012.5100","journal-title":"Antioxid Redox Signal"},{"key":"1676_CR36","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1017\/S1461145714000029","volume":"17","author":"P Sanchez-Blazquez","year":"2014","unstructured":"Sanchez-Blazquez P, Rodriguez-Munoz M, Herrero-Labrador R et al (2014) The calcium-sensitive Sigma-1 receptor prevents cannabinoids from provoking glutamate NMDA receptor hypofunction: implications in antinociception and psychotic diseases. Int J Neuropsychopharmacol 17:1943\u20131955. \n                    https:\/\/doi.org\/10.1017\/S1461145714000029","journal-title":"Int J Neuropsychopharmacol"},{"key":"1676_CR37","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S0014-2999(02)02119-2","volume":"450","author":"J Sawynok","year":"2002","unstructured":"Sawynok J, Reid A (2002) Modulation of formalin-induced behaviors and edema by local and systemic administration of dextromethorphan, memantine and ketamine. Eur J Pharmacol 450:153\u2013162","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"1676_CR38","doi-asserted-by":"publisher","first-page":"ENEURO.0116-15.","DOI":"10.1523\/ENEURO.0116-15.2016","volume":"3","author":"Amelie Soumier","year":"2016","unstructured":"Soumier A, Carter RM, Schoenfeld TJ, Cameron HA (2016) New hippocampal neurons mature rapidly in response to ketamine but are not required for its acute antidepressant effects on neophagia in rats. eNeuro. 3. \n                    https:\/\/doi.org\/10.1523\/ENEURO.0116-15.2016","journal-title":"eneuro"},{"key":"1676_CR39","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1097\/ALN.0b013e31822f16ae","volume":"115","author":"J Wang","year":"2011","unstructured":"Wang J, Goffer Y, Xu D, Tukey DS, Shamir DB, Eberle SE, Zou AH, Blanck TJJ, Ziff EB (2011) A single subanesthetic dose of ketamine relieves depression-like behaviors induced by neuropathic pain in rats. Anesthesiology 115:812\u2013821. \n                    https:\/\/doi.org\/10.1097\/ALN.0b013e31822f16ae","journal-title":"Anesthesiology"},{"key":"1676_CR40","doi-asserted-by":"publisher","first-page":"2556","DOI":"10.2174\/1381612824666180730104707","volume":"24","author":"JM Witkin","year":"2018","unstructured":"Witkin JM, Knutson DE, Rodriguez GJ, Shi S (2018) Rapid-acting antidepressants. Curr Pharm Des 24:2556\u20132563. \n                    https:\/\/doi.org\/10.2174\/1381612824666180730104707","journal-title":"Curr Pharm Des"},{"key":"1676_CR41","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/mp.2017.255","volume":"23","author":"P Zanos","year":"2018","unstructured":"Zanos P, Gould TD (2018) Mechanisms of ketamine action as an antidepressant. Mol Psychiatry 23:801\u2013811. \n                    https:\/\/doi.org\/10.1038\/mp.2017.255","journal-title":"Mol Psychiatry"},{"key":"1676_CR42","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3389\/fpsyt.2016.00047","volume":"7","author":"MWB Zhang","year":"2016","unstructured":"Zhang MWB, Ho RCM (2016) Controversies of the effect of ketamine on cognition. Front Psychiatry 7:47. \n                    https:\/\/doi.org\/10.3389\/fpsyt.2016.00047","journal-title":"Front Psychiatry"},{"key":"1676_CR43","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/j.neuropharm.2005.01.005","volume":"48","author":"S-Y Zhuang","year":"2005","unstructured":"Zhuang S-Y, Bridges D, Grigorenko E, McCloud S, Boon A, Hampson RE, Deadwyler SA (2005) Cannabinoids produce neuroprotection by reducing intracellular calcium release from ryanodine-sensitive stores. Neuropharmacology 48:1086\u20131096. \n                    https:\/\/doi.org\/10.1016\/j.neuropharm.2005.01.005","journal-title":"Neuropharmacology"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-019-01676-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00210-019-01676-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-019-01676-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,25]],"date-time":"2020-06-25T23:11:51Z","timestamp":1593126711000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00210-019-01676-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,27]]},"references-count":43,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["1676"],"URL":"https:\/\/doi.org\/10.1007\/s00210-019-01676-5","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,27]]},"assertion":[{"value":"14 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was carried out in accordance with ethical standards in all aspects.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}